COVID-19 is the crisis of our generation. As decision-makers carve out a path forward, they need the latest data at their fingertips to ensure we can protect everyone’s lives and livelihoods. That’s why we created the ONE Africa COVID-19 Tracker, which compiles data and analysis from global institutions, governments, and universities about the impacts of the pandemic across Africa. The data in our tracker is timely, transparent, and telling. We deliver up-to-date intel on the most pressing and dynamic elements...
Having safe and effective vaccines to fight COVID-19 within a year of the first reported cases is a historic scientific achievement. But as our animated series “Pandemica” has illustrated, unless the world prioritizes fair and equal vaccine distribution, we’re at risk of prolonging the pandemic. What happens in the next six weeks will determine the trajectory of this pandemic for the next six months. This is a critical point in the pandemic, as world leaders can either turn the...
As the COVID-19 pandemic continues, the creation of safe and effective vaccines to fight the virus within a year of the first reported cases is a huge scientific achievement. It has shifted the conversation from “if” there will be an end to the pandemic to “when.” Even with vaccines being rolled out, we know that we won’t beat this disease fully until we beat it everywhere, so we need to ensure vaccines and medicines reach people at risk wherever they...
The entire world is overwhelmed by a virus that has stalled economic construction efforts that have been in place for more than a century, and continues to threaten millions of jobs worldwide. In the quest for recovery, countries, and leaders have directed the efforts of the world’s laboratories to find a vaccine as quickly as possible. Scientists have taken unprecedented steps to create safe and effective vaccines and offer immunity to humanity. In this race, Africa was not outdone. Before...
Having safe and effective vaccines a full year since the first reported cases of COVID-19 is a historic scientific achievement. It has shifted the conversation from “if” we will see an end to the pandemic to “when.” But COVID-19 will not end with just a vaccine. It ends when everyone, everywhere has access to it. If the virus remains unchecked anywhere in the world, it will continue to move across borders, mutate, and drastically impact the global economy. Prioritizing the...
Less than a year since the COVID-19 pandemic started, AstraZeneca, Pfizer/BioNTech, and Moderna have created safe and effective vaccines against the virus, and some nations have begun vaccinating their citizens. Although this is great news and a major scientific achievement, the work isn’t done, and we’re seeing some signs that this accomplishment could be undermined by a failure to get the vaccine everywhere. The pandemic won’t end with just a vaccine, but when there is global access to it and...
The world is racing to find safe and effective vaccines against COVID-19, and world leaders are making deals for promising COVID-19 vaccine candidates and speaking about the need for vaccine equity. As this happens, we want them to know that we’re watching. That’s why in September, ONE launched the Vaccine Access Test. The Test provides the framework to answer one question: Are the actions taken by world leaders and players moving us closer to or further from an equitable outcome...
To ensure that the world responds effectively to COVID-19 and the challenges it has presented, world leaders, companies, and individuals need to come together in a single response effort — a global pandemic of this magnitude demands a global response. Finding an effective vaccine is a key part of a global response plan. But that is only half the battle. After an effective vaccine for COVID-19 becomes available, world leaders must come together to ensure there is equitable access to a...